169 related articles for article (PubMed ID: 28854773)
21. Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma.
Ohnishi T; Yasuda I; Nishigaki Y; Hayashi H; Otsuji K; Mukai T; Enya M; Omar S; Soehendra N; Tomita E; Moriwaki H
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e410-5. PubMed ID: 17683503
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous intraductal radiofrequency ablation for treatment of biliary stent occlusion: A preliminary result.
Xia N; Gong J; Lu J; Chen ZJ; Zhang LY; Wang ZM
World J Gastroenterol; 2017 Mar; 23(10):1851-1856. PubMed ID: 28348491
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for malignant biliary obstruction: A case report and review of the literature.
Guan L; Wang J; Gao K; Zhai R
J Cancer Res Ther; 2016 Dec; 12(Supplement):C221-C224. PubMed ID: 28230021
[TBL] [Abstract][Full Text] [Related]
24. A case of hepatocellular carcinoma treated by radiofrequency ablation confirming the adjacent major bile duct under hybrid contrast mode through a biliary drainage catheter.
Imai Y; Hirooka M; Ochi H; Koizumi Y; Ohno Y; Watanabe T; Tokumoto Y; Kumagi T; Abe M; Hiasa Y
Clin J Gastroenterol; 2015 Oct; 8(5):318-22. PubMed ID: 26319539
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.
Qin LX; Tang ZY
World J Gastroenterol; 2003 Mar; 9(3):385-91. PubMed ID: 12632482
[TBL] [Abstract][Full Text] [Related]
26. Sonographic features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma and intraductal cholangiocarcinoma.
Kim NR; Kim SH; Lee JM; Lee KH; Kim YJ; An SK; Jung AY; Han JK; Choi BI
J Ultrasound Med; 2004 Oct; 23(10):1283-91. PubMed ID: 15448317
[TBL] [Abstract][Full Text] [Related]
27. Management of the mucin filled bile duct. A complication of intraductal papillary mucinous tumor of the pancreas.
Patel A; Lambiase L; Decarli A; Fazel A
JOP; 2005 May; 6(3):255-9. PubMed ID: 15883476
[TBL] [Abstract][Full Text] [Related]
28. Intraductal Hepatocellular Carcinoma without Parenchymal Tumor: A Case Report.
Ramakrishna B; Shah GJ; Vyas F
J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S77-9. PubMed ID: 21814761
[TBL] [Abstract][Full Text] [Related]
29. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma.
Schmidt A; Bloechinger M; Weber A; Siveke J; von Delius S; Prinz C; Schmitt W; Schmid RM; Neu B
United European Gastroenterol J; 2016 Aug; 4(4):570-9. PubMed ID: 27536367
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Sorafenib in Unresectable Hepatocellular Carcinoma with Bile Duct Invasion.
Tanaka T; Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
Oncology; 2020; 98(9):621-629. PubMed ID: 32434180
[TBL] [Abstract][Full Text] [Related]
31. Metallic stents in malignant biliary obstruction: prospective long-term clinical results.
Lee BH; Choe DH; Lee JH; Kim KH; Chin SY
AJR Am J Roentgenol; 1997 Mar; 168(3):741-5. PubMed ID: 9057527
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma.
Buerlein RCD; Wang AY
Gastrointest Endosc Clin N Am; 2019 Apr; 29(2):351-367. PubMed ID: 30846158
[TBL] [Abstract][Full Text] [Related]
33. Experimental bile duct protection by intraductal cooling during radiofrequency ablation.
Stippel DL; Bangard C; Kasper HU; Fischer JH; Hölscher AH; Gossmann A
Br J Surg; 2005 Jul; 92(7):849-55. PubMed ID: 15892161
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous Biliary Stent Placement in Palliation of Malignant Bile Duct Obstruction.
Liu F; Zhang CQ; Wang GC; Liu FL; Xu HW; Xu L; Feng K
Gastroenterology Res; 2009 Oct; 2(5):289-294. PubMed ID: 27956973
[TBL] [Abstract][Full Text] [Related]
35. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review.
Rebhun J; Shin CM; Siddiqui UD; Villa E
World J Gastrointest Endosc; 2023 Mar; 15(3):177-190. PubMed ID: 37034966
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results.
Pai M; Valek V; Tomas A; Doros A; Quaretti P; Golfieri R; Mosconi C; Habib N
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):235-40. PubMed ID: 23842684
[TBL] [Abstract][Full Text] [Related]
38. Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinoma.
Varin E; Beunon P; N'Kontchou G; Petit A; Pescatori LC; Ganne-Carrié N; Nault JC; Seror O; Sutter O
Eur Radiol; 2024 Feb; ():. PubMed ID: 38334763
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic radiofrequency ablation for cholangiocarcinoma.
Wadsworth CA; Westaby D; Khan SA
Curr Opin Gastroenterol; 2013 May; 29(3):305-11. PubMed ID: 23449026
[TBL] [Abstract][Full Text] [Related]
40. Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: A prospective study.
Yang J; Shen H; Jin H; Lou Q; Zhang X
Photodiagnosis Photodyn Ther; 2016 Dec; 16():110-118. PubMed ID: 27720942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
